Clinical trial
The Effect of Intravitreal Bevacizumab (Avastin) Injection on Retinal Blood-Flow Velocity in Patients With Choroidal Neovascularization
NCT01298440 is registered in ClinicalTrials.gov with Optical Imaging, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intravitreal Bevacizumab (Avastin) Injection on Retinal Blood-Flow Velocity in Patients With Choroidal Neovascularization
- Lead sponsor
- Optical Imaging, Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- June 30, 2008
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.